Akorn Debt to Equity Ratio 2006-2018 | AKRX

Current and historical debt to equity ratio values for Akorn (AKRX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $0.841B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $60.065B 10.56
Teva Pharmaceutical Industries (TEVA) Israel $23.683B 6.19
Mylan (MYL) United Kingdom $18.856B 7.97
Dr Reddy's Laboratories (RDY) India $5.512B 32.91
Supernus Pharmaceuticals (SUPN) United States $2.678B 33.57
AxoGen (AXGN) United States $1.823B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.799B 3.03
Assembly Biosciences (ASMB) United States $0.856B 0.00
Homology Medicines (FIXX) United States $0.815B 0.00
CymaBay Therapeutics (CBAY) United States $0.776B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.771B 71.87
Adamas Pharmaceuticals (ADMS) United States $0.730B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.613B 0.00
Voyager Therapeutics (VYGR) United States $0.591B 0.00
Corium (CORI) United States $0.290B 0.00
Teligent (TLGT) United States $0.205B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.141B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Versartis (VSAR) United States $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.062B 0.00
Aevi Genomic Medicine (GNMX) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Agile Therapeutics (AGRX) United States $0.018B 0.00
Acasti Pharma (ACST) Canada $0.015B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00